Change in consolidation method due to NS Pharma, Inc.'s provisional closing
First written in FY2021-Q2. . Latest entry: FY2021.
3 other companies' latest entry also says "Other".
- FY2021Consolidation period extended to 15 monthsAnnual report
「As a result of this change, the current consolidated fiscal year covers the 15 months from 1 January 2020 to 31 March 2021, and adjustments have been made through the consolidated statement of income.」
The consolidation period for NS Pharma, Inc. based on provisional accounts increased from 12 months through the previous quarter to 15 months for the current fiscal year. - FY2021-Q3Consolidation period extended to 12 monthsAnnual report
「As a result of this change, the current third-quarter year-to-date consolidated period covers the 12 months from 1 January 2020 to 31 December 2020, and adjustments have been made through the consolidated statement of income.」
Regarding the change in the consolidation method based on provisional accounts prepared by NS Pharma, Inc., the third-quarter year-to-date period covers the 12 months from January through December 2020. - FY2021-Q2First statedAnnual report
「To obtain more appropriate management information and disclose quarterly consolidated financial statements following the start of recording external sales by NS Pharma, Inc., the company has changed its method from the second quarter of the current fiscal year to conduct a provisional closing on the quarterly consolidated closing date. As a result of this change, the six months ended the second quarter includes 9 months of consolidation from 1 January 2020 to 30 September 2020, with adjustments made through the consolidated income statement.」
Triggered by the start of recording external sales by NS Pharma, Inc., the Company changed its method from the current second-quarter consolidated accounting period to preparing provisional accounts as of each quarterly consolidated closing date, and consolidated the nine-month period from 1 January to 30 September 2020.